ZTS reports Q3 results on Thursday morning having recovered sharply from its year-long slide, up 6.1% over the past week to $82.99 and 19% over the past month, a rebound that has outpaced all of its closest peers by a wide margin. Options traders are not fully convinced the rally holds. The put/call ratio has climbed to 0.54, nearly two standard deviations above its 20-day average…
ZTS cost to borrow jumps 139% in a week to 0.41%, though availability remains abundant at 3,068% of short interest.
Key data as of 4 Nov 2026
ZTS cost to borrow jumps 139% in a week to 0.41%, though availability remains abundant at 3,068% of short interest.
ZTS Jefferies downgrade to Hold, PT slashed to $83 from $103. Stock at $79.59, implying 4.3% downside from new target. Consensus rating now Hold with mean PT $94.43.
Zoetis heads into its August 5 earnings release having lost more than a third of its value this year, with the Street's conviction in its recovery sharply divided. The most telling pre-print signal is the relentless…
Options traders and short sellers are converging on ZTS from multiple angles. The stock has dropped 4.3% over the past month. Earnings land on August 5. The loudest signal here is the relentless analyst price-target…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZTS — free to start on ORTEX.
Sign up for free →Open ZTS on ORTEX